Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 46, 2011 - Issue 4
Submit an article Journal homepage
411
Views
13
CrossRef citations to date
0
Altmetric
Esophagus

Clinical and pathophysiological consequences of on-demand treatment with PPI in endoscopy-negative reflux disease. Is rebound hypersecretion of acid a problem?

Paul Juul-Hansen Rasta Medical Centre, Lørenskog, NorwayCorrespondence[email protected]
&
Andreas Rydning Department of Gastroenterology, Akershus University Hospital, Lørenskog, Norway; Faculty Division Akershus University Hospital, University of Oslo, Norway
Pages 398-405 | Received 27 Jun 2010, Accepted 01 Nov 2010, Published online: 09 Dec 2010

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

David Peura, Anne Le Moigne, Charles Pollack, Peter Nagy & Tore Lind. (2016) A 14-day regimen of esomeprazole 20 mg/day for frequent heartburn: durability of effects, symptomatic rebound, and treatment satisfaction. Postgraduate Medicine 128:6, pages 577-583.
Read now
Anders Bergh Lødrup, Christina Reimer & Peter Bytzer. (2013) Systematic review: symptoms of rebound acid hypersecretion following proton pump inhibitor treatment. Scandinavian Journal of Gastroenterology 48:5, pages 515-522.
Read now

Articles from other publishers (11)

Hironori Tanaka, Toshihisa Takeuchi, Shinya Nishida, Hitosi Hongo, Michiaki Takii, Takeshi Higashino, Makoto Sanomura, Hirota Miyazaki, Masahiro Hoshimoto, Tsuguhiro Kimura, Masahiro Sakaguchi, Takashi Abe, Akitoshi Hakoda, Noriaki Sugawara, Taro Iwatsubo, Shinpei Kawaguchi, Kazuhiro Ota, Yuichi Kojima & Kazuhide Higuchi. (2023) Examination on Factors Affecting Symptom Change after Drug Withdrawal in Patients with Mild Erosive Gastroesophageal Reflux Disease Undergoing Symptom-Controlled Maintenance Therapy with Acid-Secretion Inhibition Drugs. Digestion 104:4, pages 270-282.
Crossref
Philip O. Katz, Kerry B. Dunbar, Felice H. Schnoll-Sussman, Katarina B. Greer, Rena Yadlapati & Stuart Jon Spechler. (2022) ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease. American Journal of Gastroenterology 117:1, pages 27-56.
Crossref
Helgadottir & Bjornsson. (2019) Problems Associated with Deprescribing of Proton Pump Inhibitors. International Journal of Molecular Sciences 20:21, pages 5469.
Crossref
David A. Peura, Anne Le Moigne, Heather Wassel & Charles Pollack. (2018) Sustained efficacy following resolution of frequent heartburn with an over-the-counter regimen of esomeprazole 20 mg or placebo for 14 days: two randomized trials. BMC Gastroenterology 18:1.
Crossref
Michaël Rochoy, Sébastien Dubois, Raymond Glantenet, Sophie Gautier & Marc Lambert. (2018) Le rebond d’acidité gastrique après arrêt d’un inhibiteur de la pompe à protons : revue narrative de littérature. Therapies 73:3, pages 237-246.
Crossref
Hólmfridur Helgadóttir, David C. Metz, Yu-Xiao Yang, Andrew D. Rhim & Einar S. Björnsson. (2014) The effects of long-term therapy with proton pump inhibitors on meal stimulated gastrin. Digestive and Liver Disease 46:2, pages 125-130.
Crossref
Marcus Zulian Teixeira. (2013) Efeito rebote dos fármacos modernos: evento adverso grave desconhecido pelos profissionais da saúde. Revista da Associação Médica Brasileira 59:6, pages 629-638.
Crossref
Marcus Zulian Teixeira. (2013) Immunomodulatory drugs (natalizumab), worsening of multiple sclerosis, rebound effect and similitude. Homeopathy 102:3, pages 215-224.
Crossref
Ronnie Fass. (2012) Alternative Therapeutic Approaches to Chronic Proton Pump Inhibitor Treatment. Clinical Gastroenterology and Hepatology 10:4, pages 338-345.
Crossref
Nimish Vakil. (2012) Prescribing Proton Pump Inhibitors. Drugs 72:4, pages 437-445.
Crossref
Yaron Niv. (2011) Gradual cessation of proton pump inhibitor (PPI) treatment may prevent rebound acid secretion, measured by the alkaline tide method, in dyspepsia and reflux patients. Medical Hypotheses 77:3, pages 451-452.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.